UnicomIG
0.1.0 - ci-build

UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/ and changes regularly. See the Directory of published versions

Example Bundle: 014-CanestenKombi-FI-FullProduct

Canesten® Kombi 500 mg emätinpuikko + 10 mg/g emulsiovoide

MPID: FI-100004966-18300
PMSID: FI00000003

Full name: Canesten® Kombi 500 mg emätinpuikko + 10 mg/g emulsiovoide

- Invented name part: Canesten Kombi

Name usage: Finnish (Republic of Finland)

Authorised dose form: Cream + pessary

Legal status of supply: Medicinal Product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000095693 clotrimazole
  • G01AF02 clotrimazole

Marketing Authorisation 1 of 1

Authorisation number: 18300

Region: Republic of Finland

Marketing authorisation holder: Bayer Oy

Identifier:

  • LOC-100004966
  • ORG-100000155

Status: Valid - Renewed/Varied (2009-11-11)

Package 1 of 1

PCID: FI-100004966-18300-541276

Description:
Yksi emätinpuikko läpipainopakkauksessa. Läpipainopakkauksen alaosa on pehmeää alumiini/polyamidi/polyvinyylikloridi -foliota ja kansi kovaa alumiinifoliota. Kansiosa on kuumasaumattu alaosaan. Pakkauksessa on polyetyleenistä valmistettu asetin. 20 g emulsiovoidetta alumiiniputkessa

Marketing status:

  • Republic of Finland: Marketed

Pack size:

  • 1 Pessary
  • 1 Tube

Package: 1 Box (Cardboard)

Containing: Applicator


Package: 1 Blister

Containing: 1

Manufactured Item

Dose form: Pessary

Unit of presentation: Pessary

Ingredient

Role: Active

Substance: CLOTRIMAZOLE

Presentation strength: 500 milligram(s) / 1 Pessary


Package: 1 Tube (Aluminium)

Containing: 20 gram(s)

Manufactured Item

Dose form: Cream

Unit of presentation: Tube

Ingredient

Role: Active

Substance: CLOTRIMAZOLE

Concentration strength: 10 milligram(s) / 1 gram(s)

Administrable Product (1 of 2)

Dose form: Cream

Unit of presentation: Tube

Route of administration:

  • Cutaneous use

Ingredients:

Ingredient

Role: Active

Substance: CLOTRIMAZOLE

Concentration strength: 10 milligram(s) / 1 gram(s)

Administrable Product (2 of 2)

Dose form: Pessary

Unit of presentation: Pessary

Route of administration:

  • Vaginal use

Ingredients:

Ingredient

Role: Active

Substance: CLOTRIMAZOLE

Presentation strength: 500 milligram(s) / 1 Pessary